Nexalin Technology, Inc. SEC filings NXL

Nexalin Technology, Inc. has 204 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form ARS, was filed on Jul 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.

Nexalin Technology, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Jul 10, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
10-K/A Amended annual report Sep 23, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 15, 2025 Dec 31, 2024
10-K Annual report Mar 14, 2025 Dec 31, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
10-K Annual report Mar 27, 2023 Dec 31, 2022

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NXL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
, Emerging growth company
SEC CIK
1527352

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.